Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-11

Clinical Trial Update: Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of CP-751,871 in combination with carboplatin and paclitaxel in advanced non-small cell lung cancer. Results were posted on 2013-04-11.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CP-751,871 (dalotuzumab)

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: COMPLETED | Results posted: 2013-04-11